Espansione Group's Light Modulation Low-level Light Therapy (LLLT) is used in ophthalmology and dermatology

Ocular clues to a neurological conditions help clinicians understand neuromyelitis optica spectrum disorder (NMOSD)

The European Commission will assess the marketing authorisation for Eydenzelt (reference product Eylea)

A confirmed diagnosis of familial exudative vitreoretinopathy aids in several aspects of patient management

The PFS is approved for treatment of neovascular age-related macular degeneration, diabetic macular oedema and macular oedema following retinal vein occlusion

Phenocell and Amarna Therapeutics were awarded the grant by Eureka’s Eurostars initiative, co-funded by the European Union

A retrospective study assessed elevated neutrophil-to-lymphocyte ratios and systemic immune-inflammation index levels in patients with different subtypes of DMO

The research findings supported the hypothesis that a mild reduction in retinal contrast can slow myopia progression in young children

Clinicians must consider redefining the metrics and intention behind functional outcomes, according to experts from the European Association for the Study of Diabetic Eye Complications

Presentation closely resembled mitogen-activated extracellular signal-regulated kinase inhibitor–associated retinopathy

The annual meeting brought fourth announcements and insights from companies in the retina care space

Dr Wykoff addressed the top three questions retina specialists have about retinal non-perfusion

EAB members from Ophthalmology Times Europe, Ophthalmology Times and Modern Retina are presenting in Florence

Breakthrough technologies are raising the ceiling for functional visual outcomes

What to expect from 4 days in the Fortezza de Basso

The differential recruitment of the dorsal and ventral visual streams